Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors

NEXT STORY
VBL Therapeutics to Present Data on New Investigator-Sponsored Phase 2 Trial of VB-111 in Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting
PREV STORY
Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Santhera Launches U.S. Expanded Access Program with Idebenone for Patients with Duchenne Muscular Dystrophy (DMD)

Liestal, Switzerland, February 6, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces the launch of a U.S. ...

author_avatar
NASDAQ Market News

Celyad to Present at the Cantor Fitzgerald Global Healthcare Conference

MONT-SAINT-GUIBERT, Belgium, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels:CYAD) (Euronext Paris:CYAD) (NASDAQ:CYAD), a ...

author_avatar
NASDAQ Market News

Soricimed Announces Changes to its Board of Directors

MONCTON, New Brunswick, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Soricimed Biopharma Inc. ("Soricimed"), a ...

author_avatar
NASDAQ Market News